Research and Markets: Among The Companies Active in the R&D Field of Muscarinic Receptor Agonists & Antagonists Are Glaxosmithkline, Novartis, Astrazeneca, Ucb Pharma and Many Others

Dublin, Jun 27, 2008 (M2 PRESSWIRE via COMTEX) -- NVS | Quote | Chart | News | PowerRating -- Research and Markets (http://www.researchandmarkets.com/research/85931c/competitor_analysi) has announced the addition of the "Competitor Analysis: Muscarinic Receptor Agonists & Antagonists" report to their offering.

Product description

The Competitive Intelligence Report Muscarinic Receptor Agonists & Antagonists as of November 2007 provides a competitor analysis in the development pipeline of novel Muscarinic Receptor Agonists & Antagonists for the treatment of cognitive impairment, overactive bladder or urinary incontinence and chronic obstructive pulmonary disease (COPD). Among the companies active in the R&D field of Muscarinic Receptor Agonists & Antagonists are GlaxoSmithKline, Novartis, AstraZeneca, UCB Pharma and many others.

The report includes a compilation of current active projects in research and development of Muscarinic Receptor Agonists & Antagonists for the treatment of cognitive impairment, overactive bladder or urinary incontinence and chronic obstructive pulmonary disease (COPD). Competitor projects are listed in a tabular format providing Information on:

Drug Codes, Target / Mechanism of Action, Class of Compound, Company, Therapeutic Area, Product Category, Indication, R&D Stage and additional comments with a hyperlink leading to the source of information.

The Competitive Intelligence Report Muscarinic Receptor Agonists & Antagonists as of November 2007 provides a competitor analysis in the development pipeline of novel Muscarinic Receptor Agonists & Antagonists for the treatment of cognitive impairment, overactive bladder or urinary incontinence and chronic obstructive pulmonary disease (COPD). Among the companies active in the R&D field of Muscarinic Receptor Agonists & Antagonists are GlaxoSmithKline, Novartis, AstraZeneca, UCB Pharma and many others

Key Topics Covered:

Muscarinic Receptor Agonists

Muscarinic Receptor Antagonists for genitourinary diseases

Muscarinic Receptor Antagonists for pulmonary & respiratory diseases

About La Merie

For more information visit http://www.researchandmarkets.com/research/85931c/competitor_analysi

CONTACT: Laura Wood, Senior Manager, Research and Markets Fax: +1 646 607 1907 (from USA) Fax: +353 1 481 1716 (from rest of the world) e-mail: press@researchandmarkets.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Morning Coffee with TradingMarkets -- Free Newsletter

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index